We use cookies on our site to analyze traffic, enhance your experience, and provide you with tailored content.
For more information visit our privacy policy.Common Contracts
2 similar License Agreement contracts by International Stem Cell CORP
EX-10.1 2 d486823dex101.htm EX-10.1 AMENDED AND RESTATED LICENSE AGREEMENT (ACT IP)License Agreement • May 5th, 2020 • California
This Amended and Restated License Agreement (“Agreement”) is made and entered into this day of February, 2013 (the “Effective Date”), by and between Advanced Cell Technology, Inc., a Delaware corporation with offices located at 33 Locke Drive, Marlborough MA 01752 (“LICENSOR”), and International Stem Cell Corporation (the successor in interest to PacGen Cellco, LLC), a Delaware corporation with offices located at 5950 Priestly Drive Carlsbad, CA 92008 (“LICENSEE”) (LICENSOR and LICENSEE sometimes hereinafter referred to individually as a “Party” and collectively as the “Parties”).
Standard Contracts
AMENDED AND RESTATED LICENSE AGREEMENT (ACT IP)License Agreement • February 14th, 2013 • International Stem Cell CORP • Pharmaceutical preparations • California
This Amended and Restated License Agreement (“Agreement”) is made and entered into this day of February, 2013 (the “Effective Date”), by and between Advanced Cell Technology, Inc., a Delaware corporation with offices located at 33 Locke Drive, Marlborough MA 01752 (“LICENSOR”), and International Stem Cell Corporation (the successor in interest to PacGen Cellco, LLC), a Delaware corporation with offices located at 5950 Priestly Drive Carlsbad, CA 92008 (“LICENSEE”) (LICENSOR and LICENSEE sometimes hereinafter referred to individually as a “Party” and collectively as the “Parties”).